3.
CRISPR and Genome Editing Technologies
CRISPR-Cas9 is a revolutionary genome-editing technology derived from a bacterial immune
system. It allows scientists to make precise, targeted changes to the DNA of living organisms. The
system includes a guide RNA that directs the Cas9 nuclease to a specific DNA sequence, where it
induces a double-strand break. The cell then repairs this break through non-homologous end joining
or homology-directed repair, which can be exploited to insert or delete genes. CRISPR has vast
applications in research, agriculture, and medicine. In humans, it holds promise for correcting
genetic disorders like sickle cell anemia and cystic fibrosis. However, ethical concerns arise over
germline editing and potential off-target effects, necessitating cautious development and regulation.